Daily Highlights

Preview 21 Total

ISTH Congress Chair Beverley Hunt Welcomes You to ISTH 2022

Beverley Hunt, M.D, O.B.E., extends a warm welcome from London to all ISTH 2022 participants, both online and in-person.

SSC Chair Marc Carrier Invites Your Participation in the SSC

SSC Chair invites ISTH members to get involved in the exciting work of the Scientific and Standardization Committee (SSC).

Are You Ready for the Next Advances in Haemophilia Care? [Supported Content]

Download the ISTH 2022 App for Access on the Go

30 Years Later: Looking Back on Professor Dominique Meyer’s Ascent to Becoming the First Female ISTH Council Chair

Communicating Science Online: Getting Started and the ‘Dos and Don’ts’

Download and View the ISTH 2022 Abstracts

Lessons From Working Abroad as a Scientist

How the ISTH Congress Impacts Members from Reach-the-World Countries

How Uncertainty and An Unexpected Email Propelled Me Into Thrombosis Research

Flora Peyvandi: Highlights on the Professional Journey of the Next ISTH President

Diagnosing Yourself: How Platelets Became the Guide to One Hematologist’s Health Problems

From the Invisible Hemophilia Carrier to the Lyonization Phenomena: A Long Way to Make Women and Girls With Hemophilia Visible

My First ISTH Congress: How Attending In-Person Again Rekindles Memories of the Past

Harnessing the Power of Visual Science Communication

ISTH Announces Official Twitter Ambassadors for the ISTH 2022 Congress in London

Apply Now to Become the Next Editor-in-Chief of JTH or RPTH

Claim Your Virtual Delegate Bag With Unique Offers and Promotions

Visit Supported Symposia and Product Theaters for Latest Updates

Visit Exhibition in London and Virtually

RPTH Publishes Illustrated State-of-the-Art Capsules in Conjunction With ISTH 2022

Five Revered Leaders Honored With ISTH Esteemed Career Awards at ISTH 2022 Congress

Factor XII Heavy Chain Structure

July 9, 2022 | Jonas Emsley, B.Sc., Ph.D., University of Nottingham, Nottingham, United Kingdom

argenx Welcomes You to the ISTH 2022 Congress [Supported Content]

High Rate of Recurrent Thrombosis in Children with Unprovoked Venous Thromboembolism

July 9, 2022 | Hilary Whitworth, M.D., Children's Hospital of Philadelphia, Philadelphia, U.S.

The Rich Inner Life of a Thrombus – “Next Generation” Analysis of Platelet Activity During Thrombus Formation in Vivo

July 9, 2022 | Niklas Boknäs, M.D., M.Sc., Ph.D., Linköping University, Department of Hematology and Department of Biomedical and Clinical Sciences, Linköping, Sweden; Pia Larsson, Ph.D., Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Management of Thrombotic Thrombocytopenic Purpura (TTP) Without Plasma Exchange: An Update on the Austrian Experience

July 9, 2022 | Paul Knoebl, M.D., Medical University of Vienna, Vienna, Austria

Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors

New Survey: Assessing Patient Awareness & Satisfaction About Information Received on the Potential Risks of Cancer-Associated VTE and Anticoagulation

Factor X – Protease-Activated Receptor-2 Signaling in the Regulation of Diet-Induced Obesity

July 10, 2022 | Dilraj Kaur, Ph.D. Candidate, University Medical center of Johannes Gutenberg-University, Mainz, Germany

Both α- and γ-Chain Crosslinks Mediated by FXIIIa Affect Fibrin Fiber Resistance to Rupture

July 10, 2022 | Timea Feller, Ph.D., University of Leeds, Leeds, U.K.

A Dose-Escalation Phase 1 Clinical Trial of Autologous iPSC-Derived Platelets (iPLAT1)

July 10, 2022 | Naoshi Sugimoto, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan

ISTH 2022 Opening Ceremony Welcomes Thousands From Around the Globe

A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico Study

July 10, 2022 | Matthias M. Engelen, M.D., University Hospitals Leuven, Leuven, Belgium

Arterial Thromboembolism Risk Assessment Model in Hospitalized COVID-19 Patients

July 10, 2022 | Pin Li, Ph.D., Henry Ford Health, Detroit, U.S.

Validating Direct Oral Anticoagulants (DOACs) for Use in Children by the Throm-PED DOAC Registry of the International Pediatric Thrombosis Network

July 10, 2022 | Susanne Holzhauer, M.D., Charité University Medicine, Berlin, Germany

RPTH Editor Mary Cushman Celebrates Debut Impact Factor

Research and Practice in Thrombosis and Haemostasis (RPTH) recently received its debut Impact Factor of 5.953. Listen as RPTH Editor-in-Chief Mary Cushman talks about this momentous achievement and RPTH initiatives.

JTH Journal Editors Tout Rising Impact Factor

The Journal of Thrombosis and Haemostasis (JTH) recently recorded a historic rise in Impact Factor to 16.036. Watch JTH Editors-in-Chief James Morrissey, Ph.D. and David Lillicrap, M.D., discuss the benefits of publishing with JTH.